Why the study?
Does intravenous diltiazem alter haemodynamic and radionuclide parameters in ischaemic patients?
Does intravenous diltiazem alter haemodynamic and radionuclide parameters in ischaemic patients?
Intravenous diltiazem acutely improves haemodynamic parameters by reducing blood pressure, heart rate, and vascular resistance while increasing stroke index in patients with ischaemic heart disease.
Answers are grounded in this paper and cite their sources.
Should not yet change practice in ischaemic heart disease; leaves open confirmation of acute effects in controlled trials.
To obtain multiple dose-response haemodynamic and radionuclide data on i.v. diltiazem, 12 ischaemic patients were studied during routine catheterization. At rest, following a 20 min stable control period, the effects of four doses (0.0625, 0.0625, 0.125 and 0.25 mg kg-1 diltiazem at 5 min intervals) were measured in the 3-5 min following i.v. injection. The exercise effects of the cumulative 0.5 mg kg-1 dosage were assessed by comparing a control and post drug period of supine bicycle exercise. The increase in plasma diltiazem levels correlated linearly with the administered dose and achieved therapeutic levels. There were significant dose-related reductions in systemic arterial blood pressure and vascular resistance index; the heart rate fell and cardiac stroke index increased. The calculated double-product (heart rate X systolic blood pressure) was significantly reduced. The left ventricular filling pressures, ejection fraction and cardiac volumes were unaltered. During supine bicycle exercise, the systemic diastolic blood pressure, heart rate and calculated double-product were reduced without change in other parameters. Over the dose range 0.0625-0.5 mg kg-1, diltiazem acutely increased cardiac stroke index and reduced resting heart rate. These haemodynamic data, taken together with its described coronary vasodilator activity suggest that its role in acute vasospastic angina and during angiographic procedures ought to be explored further.
No takes yet. Share an insight, caveat, or question.
Silke et al. (1987) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: